Clinical trial
Gaze Contingent Attentional Reinforcement Treatment of MDD
NCT07364981 is registered in ClinicalTrials.gov with Tel Aviv University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gaze Contingent Attentional Reinforcement Treatment of MDD
- Lead sponsor
- Tel Aviv University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2026
- Completion date
- January 1, 2030
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
major depressive disorder (mdd)